Skip to main content

Coastal Genomics Licenses Liquid Handling Tech for DNA Sample Prep

NEW YORK (GenomeWeb News) – Coastal Genomics announced that it has licensed from the BC Cancer Agency exclusive rights to a liquid handling automation technology.

The Vancouver, British Columbia-based firm said that the technology would be marketed as the Ranger automated workstation. The system, the company said, will be able to completely automate the process of agarose gel size selection of DNA fragments for between one and 96 samples in a single run.

The BC Cancer Agency's Genome Sciences Centre has been using the technology in house since 2010 and has processed more than 9,000 samples.

"The Ranger automated workstation has greatly improved sample preparation at the BCCA Genome Sciences Centre," Andy Mungall, the centre's library core group leader, said in a statement. "It's cost competitive with other methods and provides high quality output — we have been able to efficiently prepare thousands of samples for several major projects."

Coastal Genomics said that it plans to commercialize the technology this coming summer.

Financial and other terms of the license were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.